CL2007002813A1 - Compuestos derivados de [1,3]triazolo[4,5-d]pirimidina; procedimiento de preparacion; y su uso para el tratamiento de trastornos neurodegenerativos, enfermedad desmielinizante, trastornos ateroscleroticos cardio cardio y cerebrovasculares, entre otra - Google Patents
Compuestos derivados de [1,3]triazolo[4,5-d]pirimidina; procedimiento de preparacion; y su uso para el tratamiento de trastornos neurodegenerativos, enfermedad desmielinizante, trastornos ateroscleroticos cardio cardio y cerebrovasculares, entre otraInfo
- Publication number
- CL2007002813A1 CL2007002813A1 CL200702813A CL2007002813A CL2007002813A1 CL 2007002813 A1 CL2007002813 A1 CL 2007002813A1 CL 200702813 A CL200702813 A CL 200702813A CL 2007002813 A CL2007002813 A CL 2007002813A CL 2007002813 A1 CL2007002813 A1 CL 2007002813A1
- Authority
- CL
- Chile
- Prior art keywords
- cardio
- disorders
- demielinizing
- aterosclerotic
- triazolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82746006P | 2006-09-29 | 2006-09-29 | |
US82812506P | 2006-10-04 | 2006-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007002813A1 true CL2007002813A1 (es) | 2008-04-04 |
Family
ID=39230456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200702813A CL2007002813A1 (es) | 2006-09-29 | 2007-09-28 | Compuestos derivados de [1,3]triazolo[4,5-d]pirimidina; procedimiento de preparacion; y su uso para el tratamiento de trastornos neurodegenerativos, enfermedad desmielinizante, trastornos ateroscleroticos cardio cardio y cerebrovasculares, entre otra |
Country Status (22)
Country | Link |
---|---|
US (2) | US7960395B2 (es) |
EP (1) | EP2069364B1 (es) |
JP (1) | JP5422386B2 (es) |
KR (1) | KR101345085B1 (es) |
AR (1) | AR063023A1 (es) |
AT (1) | ATE537177T1 (es) |
AU (1) | AU2007300748B2 (es) |
BR (1) | BRPI0717109A2 (es) |
CA (1) | CA2664789A1 (es) |
CL (1) | CL2007002813A1 (es) |
CO (1) | CO6150165A2 (es) |
ES (1) | ES2377469T3 (es) |
HK (1) | HK1131389A1 (es) |
IL (1) | IL197293A0 (es) |
MX (1) | MX2009003005A (es) |
NO (1) | NO20091579L (es) |
NZ (1) | NZ576520A (es) |
PE (1) | PE20080973A1 (es) |
RU (1) | RU2441012C2 (es) |
TW (1) | TW200820973A (es) |
UY (1) | UY30612A1 (es) |
WO (1) | WO2008039138A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR071036A1 (es) * | 2008-03-26 | 2010-05-19 | Astrazeneca Ab | Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1. |
US8476301B2 (en) | 2011-09-13 | 2013-07-02 | Eisai R&D Management Co., Ltd. | Pyrrolidin-3-ylacetic acid derivative |
TWI543975B (zh) | 2011-09-13 | 2016-08-01 | Eisai R&D Man Co Ltd | Pyrrolidin-3-yl acetic acid derivatives |
JP5872105B2 (ja) | 2013-03-12 | 2016-03-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピロリジン−3−イル酢酸誘導体の塩およびその結晶 |
GB201811169D0 (en) * | 2018-07-06 | 2018-08-29 | Kancera Ab | New compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802729D0 (sv) | 1998-08-13 | 1998-08-13 | Astra Pharma Prod | Novel Compounds |
SE9903544D0 (sv) | 1999-10-01 | 1999-10-01 | Astra Pharma Prod | Novel compounds |
GB2359081A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active thiazolopyrimidines |
AU2001232556A1 (en) * | 2000-02-11 | 2001-08-20 | Astrazeneca Ab | Pyrimidine compounds and their use as modulators of chemokine receptor activity |
SE0101082D0 (sv) | 2001-03-27 | 2001-03-27 | Astrazeneca Ab | Novel use |
GB0221829D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
GB0221828D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
MXPA06003792A (es) * | 2003-10-07 | 2006-06-14 | Astrazeneca Ab | Nuevas 4-amino-tiazolo[4,5-d]-pirimidinas 2-sustituidas, utiles como antagonistas del receptor de quimiocina, especialmente cx3cr1. |
WO2006064228A2 (en) * | 2004-12-17 | 2006-06-22 | Astrazeneca Ab | Thiazolopyramidine compounds for the modulation of chemokine receptor activity |
AR053347A1 (es) | 2005-04-06 | 2007-05-02 | Astrazeneca Ab | Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos |
UA90707C2 (en) | 2005-04-06 | 2010-05-25 | Астразенека Аб | Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
-
2007
- 2007-09-21 TW TW096135626A patent/TW200820973A/zh unknown
- 2007-09-27 CA CA002664789A patent/CA2664789A1/en not_active Abandoned
- 2007-09-27 RU RU2009109100/04A patent/RU2441012C2/ru not_active IP Right Cessation
- 2007-09-27 NZ NZ576520A patent/NZ576520A/en unknown
- 2007-09-27 EP EP07835061A patent/EP2069364B1/en active Active
- 2007-09-27 JP JP2009530308A patent/JP5422386B2/ja active Active
- 2007-09-27 MX MX2009003005A patent/MX2009003005A/es active IP Right Grant
- 2007-09-27 ES ES07835061T patent/ES2377469T3/es active Active
- 2007-09-27 AR ARP070104275A patent/AR063023A1/es not_active Application Discontinuation
- 2007-09-27 US US11/862,743 patent/US7960395B2/en active Active
- 2007-09-27 UY UY30612A patent/UY30612A1/es not_active Application Discontinuation
- 2007-09-27 AT AT07835061T patent/ATE537177T1/de active
- 2007-09-27 BR BRPI0717109-9A patent/BRPI0717109A2/pt not_active IP Right Cessation
- 2007-09-27 AU AU2007300748A patent/AU2007300748B2/en not_active Ceased
- 2007-09-27 WO PCT/SE2007/000857 patent/WO2008039138A1/en active Application Filing
- 2007-09-27 KR KR1020097006362A patent/KR101345085B1/ko not_active IP Right Cessation
- 2007-09-28 PE PE2007001323A patent/PE20080973A1/es not_active Application Discontinuation
- 2007-09-28 CL CL200702813A patent/CL2007002813A1/es unknown
-
2009
- 2009-02-26 IL IL197293A patent/IL197293A0/en unknown
- 2009-03-05 CO CO09022856A patent/CO6150165A2/es unknown
- 2009-04-21 NO NO20091579A patent/NO20091579L/no not_active Application Discontinuation
- 2009-11-26 HK HK09111033.7A patent/HK1131389A1/xx not_active IP Right Cessation
-
2011
- 2011-01-19 US US13/009,384 patent/US20110105537A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2007300748B2 (en) | 2011-09-08 |
EP2069364B1 (en) | 2011-12-14 |
JP2010504962A (ja) | 2010-02-18 |
EP2069364A4 (en) | 2010-03-24 |
IL197293A0 (en) | 2009-12-24 |
CO6150165A2 (es) | 2010-04-20 |
TW200820973A (en) | 2008-05-16 |
AU2007300748A1 (en) | 2008-04-03 |
CA2664789A1 (en) | 2008-04-03 |
NO20091579L (no) | 2009-04-21 |
AR063023A1 (es) | 2008-12-23 |
NZ576520A (en) | 2011-08-26 |
WO2008039138A1 (en) | 2008-04-03 |
WO2008039138A8 (en) | 2009-03-19 |
KR101345085B1 (ko) | 2013-12-31 |
ES2377469T3 (es) | 2012-03-27 |
JP5422386B2 (ja) | 2014-02-19 |
MX2009003005A (es) | 2009-04-01 |
UY30612A1 (es) | 2008-05-02 |
PE20080973A1 (es) | 2008-10-02 |
HK1131389A1 (en) | 2010-01-22 |
US20080318981A1 (en) | 2008-12-25 |
EP2069364A1 (en) | 2009-06-17 |
RU2441012C2 (ru) | 2012-01-27 |
RU2009109100A (ru) | 2010-11-10 |
US20110105537A1 (en) | 2011-05-05 |
BRPI0717109A2 (pt) | 2013-10-08 |
US7960395B2 (en) | 2011-06-14 |
ATE537177T1 (de) | 2011-12-15 |
KR20090057069A (ko) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
IL204693A0 (en) | Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes | |
PT1948177E (pt) | Utilização de flibanserina para o tratamento de distúrbios pré- menopáusicos do desejo sexual | |
IL194076A (en) | Benzo Compounds - [d] - Imidzo [2, 1 – b] Thiazole-2-Ilphenyl for the Treatment of Illness | |
EP1940800A4 (en) | INNOVATIVE BICYCLIC SULFONAMIDES AS MODULATORS OF GLUCOCORTICOID RECEPTOR IN THE TREATMENT OF INFLAMMATORY DISEASES | |
ZA201004603B (en) | 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and p13 kinase inhibitors, and their synthesis | |
ZA200804830B (en) | Oil-in-water formulation of avermectins | |
BRPI0716844A2 (pt) | Inidores de quinase úteis para o tratamento de doenças proliferativas | |
CL2007001731A1 (es) | Compuestos derivados de imidazo[1,5-a]pirimidina; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras. | |
CL2008001025A1 (es) | Compuestos derivados de pirimido[5,4-d]pirimidina-2,4,6,8-tetraona; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como trastorno metabolico, dislipidemia y cancer. | |
IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
CL2007003832A1 (es) | Compuestos derivados de azaespiro; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir y tratar ansiedad, trastornos depresivos, entre otras enfermedades. | |
BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
DK1841433T3 (da) | Præparat til behandling af lidelser i centralnervesystemet | |
CL2007002813A1 (es) | Compuestos derivados de [1,3]triazolo[4,5-d]pirimidina; procedimiento de preparacion; y su uso para el tratamiento de trastornos neurodegenerativos, enfermedad desmielinizante, trastornos ateroscleroticos cardio cardio y cerebrovasculares, entre otra | |
DK1899343T3 (da) | Halogenerede pyrazolo[1,5-A]pyrimidiner, fremgangsmåder, anvendelser som GABA-A-receptorligand, sammensætninger og mellemprodukter | |
CL2008001563A1 (es) | Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras. | |
CL2007003160A1 (es) | Compuestos derivados de piridina; procedimiento de preparacion; formulacion farmaceutica; y uso en el tratamiento de enfermedades tales como trombosis, fibrosis renal, isquemia, entre otras. | |
BRPI0809970A2 (pt) | Antagonistas de cxcl 13 e seu uso para o tratamento de doenças inflamatórias | |
CL2008001648A1 (es) | Compuestos derivados de triazol[1,5-a]quinolina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como asma, epoc, artritis reumatoide, isquemia, entre otras. | |
BRPI0618789A2 (pt) | processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona | |
ZA200809016B (en) | 4, 5-Dihydro-[1,2,4] Triazolo [4,3-F] PteridinesS as protein kinase PLK1 inhibitors for the treatment of proliferative disorders | |
WO2007027233A3 (en) | Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid | |
DE602005017605D1 (de) | Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten | |
CL2008001615A1 (es) | Compuestos derivados de di(hetero)aril-ciclohexano; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cardiopatias, arritmias, isquemias, entre otras. |